We obtained the effect of GLUD1 on the survival using the GEPIA2 website, and the results indicated that higher GLUD1 expression resulted in better survival outcomes both for overall survival (Fig. 1e) and disease-free survival (Fig. 1f) of ccRCC patients. This evidence concerns the gene GLUD1 and nonpapillary renal cell carcinoma.